Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measurement of Acetylsalicylic Acid Concentration and Effect (MACE)
2017-005068-16Phase 2Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin in cardiac morbidity (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Maximal acetylsalicylic acid concentration. Started Jan 2018; status: terminated.
02
Drugs
aspirin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2017-005068-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005068-16.